nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—ABCC10—Verapamil—migraine	0.118	0.199	CbGbCtD
Doxorubicin—ABCC3—Verapamil—migraine	0.074	0.125	CbGbCtD
Doxorubicin—ABCB11—Verapamil—migraine	0.0639	0.108	CbGbCtD
Doxorubicin—ABCC1—Verapamil—migraine	0.0454	0.0769	CbGbCtD
Doxorubicin—ABCC2—Verapamil—migraine	0.0336	0.0569	CbGbCtD
Doxorubicin—ABCG2—Verapamil—migraine	0.0304	0.0515	CbGbCtD
Doxorubicin—CYP2B6—Amitriptyline—migraine	0.0269	0.0456	CbGbCtD
Doxorubicin—CYP2B6—Valproic Acid—migraine	0.0245	0.0416	CbGbCtD
Doxorubicin—CYP2B6—Verapamil—migraine	0.0214	0.0362	CbGbCtD
Doxorubicin—ABCB1—Timolol—migraine	0.0179	0.0303	CbGbCtD
Doxorubicin—CYP2D6—Timolol—migraine	0.0169	0.0286	CbGbCtD
Doxorubicin—ABCB1—Propranolol—migraine	0.016	0.027	CbGbCtD
Doxorubicin—CYP2D6—Propranolol—migraine	0.015	0.0255	CbGbCtD
Doxorubicin—ABCB1—Amitriptyline—migraine	0.0138	0.0234	CbGbCtD
Doxorubicin—CYP2D6—Amitriptyline—migraine	0.013	0.022	CbGbCtD
Doxorubicin—ABCB1—Verapamil—migraine	0.011	0.0186	CbGbCtD
Doxorubicin—CYP2D6—Verapamil—migraine	0.0103	0.0175	CbGbCtD
Doxorubicin—NOS3—middle cerebral artery—migraine	0.00971	0.102	CbGeAlD
Doxorubicin—CYP3A4—Propranolol—migraine	0.00957	0.0162	CbGbCtD
Doxorubicin—CYP3A4—Amitriptyline—migraine	0.00827	0.014	CbGbCtD
Doxorubicin—CYP3A4—Valproic Acid—migraine	0.00754	0.0128	CbGbCtD
Doxorubicin—CYP3A4—Topiramate—migraine	0.0068	0.0115	CbGbCtD
Doxorubicin—CYP3A4—Verapamil—migraine	0.00657	0.0111	CbGbCtD
Doxorubicin—NOS1—nerve—migraine	0.00271	0.0285	CbGeAlD
Doxorubicin—CBR3—trigeminal ganglion—migraine	0.00225	0.0237	CbGeAlD
Doxorubicin—NOS1—blood vessel—migraine	0.00213	0.0224	CbGeAlD
Doxorubicin—NOS3—Endothelin Pathways—CALCRL—migraine	0.00189	0.031	CbGpPWpGaD
Doxorubicin—CBR3—NRF2 pathway—SLC6A4—migraine	0.0018	0.0294	CbGpPWpGaD
Doxorubicin—AKR1A1—trigeminal ganglion—migraine	0.00173	0.0183	CbGeAlD
Doxorubicin—NOS3—blood vessel—migraine	0.00162	0.017	CbGeAlD
Doxorubicin—NOS1—Monoamine Transport—SLC6A4—migraine	0.00136	0.0222	CbGpPWpGaD
Doxorubicin—CBR3—NRF2 pathway—TGFBR2—migraine	0.00136	0.0222	CbGpPWpGaD
Doxorubicin—YWHAG—Role of Calcineurin-dependent NFAT signaling in lymphocytes—MEF2D—migraine	0.00131	0.0215	CbGpPWpGaD
Doxorubicin—NDUFS2—trigeminal ganglion—migraine	0.00131	0.0138	CbGeAlD
Doxorubicin—NDUFS3—trigeminal ganglion—migraine	0.00129	0.0136	CbGeAlD
Doxorubicin—ABCB8—Transmembrane transport of small molecules—TRPM8—migraine	0.00125	0.0205	CbGpPWpGaD
Doxorubicin—AKR1A1—cardiovascular system—migraine	0.00125	0.0132	CbGeAlD
Doxorubicin—DHCR7—trigeminal ganglion—migraine	0.00123	0.0129	CbGeAlD
Doxorubicin—NOS3—ACE Inhibitor Pathway—ACE—migraine	0.00121	0.0198	CbGpPWpGaD
Doxorubicin—NOS1—brainstem—migraine	0.00116	0.0123	CbGeAlD
Doxorubicin—NOS1—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—FOS—migraine	0.00116	0.019	CbGpPWpGaD
Doxorubicin—NOS3—neck—migraine	0.00116	0.0122	CbGeAlD
Doxorubicin—NDUFS3—brainstem—migraine	0.00114	0.012	CbGeAlD
Doxorubicin—ABCB8—head—migraine	0.00114	0.012	CbGeAlD
Doxorubicin—NDUFS7—cardiovascular system—migraine	0.00114	0.012	CbGeAlD
Doxorubicin—YWHAG—trigeminal ganglion—migraine	0.00112	0.0118	CbGeAlD
Doxorubicin—AKR1C3—Retinoid metabolism and transport—LRP1—migraine	0.00112	0.0183	CbGpPWpGaD
Doxorubicin—CBR3—head—migraine	0.0011	0.0116	CbGeAlD
Doxorubicin—ABCB8—nervous system—migraine	0.00108	0.0114	CbGeAlD
Doxorubicin—ABCB8—central nervous system—migraine	0.00104	0.011	CbGeAlD
Doxorubicin—CBR3—nervous system—migraine	0.00104	0.011	CbGeAlD
Doxorubicin—ABCB8—cerebellum—migraine	0.00102	0.0107	CbGeAlD
Doxorubicin—RALBP1—trigeminal ganglion—migraine	0.00102	0.0107	CbGeAlD
Doxorubicin—CBR3—central nervous system—migraine	0.001	0.0106	CbGeAlD
Doxorubicin—CBR3—cerebellum—migraine	0.00098	0.0103	CbGeAlD
Doxorubicin—NOS1—Alzheimers Disease—LRP1—migraine	0.000957	0.0157	CbGpPWpGaD
Doxorubicin—ABCB8—Transmembrane transport of small molecules—ATP1A3—migraine	0.00095	0.0155	CbGpPWpGaD
Doxorubicin—ABCB8—Transmembrane transport of small molecules—ATP1A2—migraine	0.00095	0.0155	CbGpPWpGaD
Doxorubicin—NOS1—cardiovascular system—migraine	0.000949	0.01	CbGeAlD
Doxorubicin—CBR1—trigeminal ganglion—migraine	0.000948	0.00999	CbGeAlD
Doxorubicin—NDUFS2—cardiovascular system—migraine	0.000943	0.00994	CbGeAlD
Doxorubicin—NOS1—Myometrial Relaxation and Contraction Pathways—RAMP1—migraine	0.000939	0.0154	CbGpPWpGaD
Doxorubicin—AKR1C3—trigeminal ganglion—migraine	0.000937	0.00987	CbGeAlD
Doxorubicin—NDUFS3—cardiovascular system—migraine	0.000932	0.00981	CbGeAlD
Doxorubicin—RALBP1—EGF/EGFR Signaling Pathway—MEF2D—migraine	0.000924	0.0151	CbGpPWpGaD
Doxorubicin—NQO1—neck—migraine	0.00088	0.00927	CbGeAlD
Doxorubicin—ABCC6—cardiovascular system—migraine	0.000863	0.00909	CbGeAlD
Doxorubicin—POR—trigeminal ganglion—migraine	0.000855	0.00901	CbGeAlD
Doxorubicin—AKR1A1—head—migraine	0.000848	0.00893	CbGeAlD
Doxorubicin—ABCB8—brain—migraine	0.000827	0.00871	CbGeAlD
Doxorubicin—YWHAG—cardiovascular system—migraine	0.000812	0.00856	CbGeAlD
Doxorubicin—ABCB8—Transmembrane transport of small molecules—HTR3A—migraine	0.000808	0.0132	CbGpPWpGaD
Doxorubicin—AKR1A1—nervous system—migraine	0.000804	0.00847	CbGeAlD
Doxorubicin—CBR3—brain—migraine	0.000796	0.00839	CbGeAlD
Doxorubicin—TOP2A—Alprenolol—Propranolol—migraine	0.000781	1	CbGdCrCtD
Doxorubicin—SLC22A16—Transmembrane transport of small molecules—TRPM8—migraine	0.000774	0.0127	CbGpPWpGaD
Doxorubicin—AKR1A1—central nervous system—migraine	0.000774	0.00815	CbGeAlD
Doxorubicin—NDUFS7—head—migraine	0.000771	0.00812	CbGeAlD
Doxorubicin—NQO1—trigeminal ganglion—migraine	0.00076	0.008	CbGeAlD
Doxorubicin—AKR1A1—cerebellum—migraine	0.000757	0.00797	CbGeAlD
Doxorubicin—NOS3—Endothelin Pathways—EDNRA—migraine	0.000754	0.0123	CbGpPWpGaD
Doxorubicin—RALBP1—cardiovascular system—migraine	0.000734	0.00773	CbGeAlD
Doxorubicin—NDUFS7—nervous system—migraine	0.000731	0.0077	CbGeAlD
Doxorubicin—NOS3—Endothelin Pathways—CALCA—migraine	0.000726	0.0119	CbGpPWpGaD
Doxorubicin—NOS3—cardiovascular system—migraine	0.000722	0.0076	CbGeAlD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—ATP1A3—migraine	0.000722	0.0118	CbGpPWpGaD
Doxorubicin—AURKA—EGF/EGFR Signaling Pathway—MEF2D—migraine	0.000718	0.0118	CbGpPWpGaD
Doxorubicin—AURKA—head—migraine	0.000717	0.00755	CbGeAlD
Doxorubicin—NDUFS7—central nervous system—migraine	0.000704	0.00741	CbGeAlD
Doxorubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—RAMP1—migraine	0.000692	0.0113	CbGpPWpGaD
Doxorubicin—NDUFS7—cerebellum—migraine	0.000688	0.00724	CbGeAlD
Doxorubicin—CBR1—cardiovascular system—migraine	0.000685	0.00721	CbGeAlD
Doxorubicin—AURKA—nervous system—migraine	0.00068	0.00716	CbGeAlD
Doxorubicin—ABCC10—trigeminal ganglion—migraine	0.000679	0.00715	CbGeAlD
Doxorubicin—AURKA—central nervous system—migraine	0.000654	0.00689	CbGeAlD
Doxorubicin—NOS1—head—migraine	0.000643	0.00677	CbGeAlD
Doxorubicin—NDUFS2—head—migraine	0.000639	0.00673	CbGeAlD
Doxorubicin—NDUFS3—head—migraine	0.000631	0.00665	CbGeAlD
Doxorubicin—AKR1A1—brain—migraine	0.000615	0.00647	CbGeAlD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—HTR3A—migraine	0.000614	0.01	CbGpPWpGaD
Doxorubicin—NOS1—nervous system—migraine	0.00061	0.00642	CbGeAlD
Doxorubicin—NDUFS2—nervous system—migraine	0.000606	0.00638	CbGeAlD
Doxorubicin—DHCR7—head—migraine	0.0006	0.00631	CbGeAlD
Doxorubicin—NDUFS3—nervous system—migraine	0.000598	0.0063	CbGeAlD
Doxorubicin—SLC22A16—Transmembrane transport of small molecules—ATP1A2—migraine	0.000587	0.0096	CbGpPWpGaD
Doxorubicin—SLC22A16—Transmembrane transport of small molecules—ATP1A3—migraine	0.000587	0.0096	CbGpPWpGaD
Doxorubicin—ABCC6—Transmembrane transport of small molecules—TRPM8—migraine	0.000587	0.0096	CbGpPWpGaD
Doxorubicin—NOS1—central nervous system—migraine	0.000587	0.00618	CbGeAlD
Doxorubicin—ABCC6—head—migraine	0.000584	0.00615	CbGeAlD
Doxorubicin—NDUFS2—central nervous system—migraine	0.000583	0.00614	CbGeAlD
Doxorubicin—NDUFS3—central nervous system—migraine	0.000576	0.00607	CbGeAlD
Doxorubicin—NOS1—cerebellum—migraine	0.000574	0.00604	CbGeAlD
Doxorubicin—AKR1C3—Diseases associated with visual transduction—LRP1—migraine	0.000572	0.00936	CbGpPWpGaD
Doxorubicin—NDUFS2—cerebellum—migraine	0.00057	0.006	CbGeAlD
Doxorubicin—DHCR7—nervous system—migraine	0.000568	0.00599	CbGeAlD
Doxorubicin—NDUFS3—cerebellum—migraine	0.000563	0.00593	CbGeAlD
Doxorubicin—NDUFS7—brain—migraine	0.000559	0.00588	CbGeAlD
Doxorubicin—YWHAG—head—migraine	0.00055	0.00579	CbGeAlD
Doxorubicin—NOS3—Myometrial Relaxation and Contraction Pathways—RAMP1—migraine	0.00055	0.00899	CbGpPWpGaD
Doxorubicin—NQO1—cardiovascular system—migraine	0.000549	0.00578	CbGeAlD
Doxorubicin—DHCR7—central nervous system—migraine	0.000547	0.00576	CbGeAlD
Doxorubicin—YWHAG—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.000541	0.00885	CbGpPWpGaD
Doxorubicin—DHCR7—cerebellum—migraine	0.000535	0.00563	CbGeAlD
Doxorubicin—CYP1B1—Estrogen Receptor Pathway—ESR1—migraine	0.000524	0.00858	CbGpPWpGaD
Doxorubicin—YWHAG—nervous system—migraine	0.000522	0.00549	CbGeAlD
Doxorubicin—AURKA—brain—migraine	0.000519	0.00547	CbGeAlD
Doxorubicin—NOS2—Signaling mediated by p38-alpha and p38-beta—ESR1—migraine	0.000519	0.00849	CbGpPWpGaD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—TRPM8—migraine	0.000513	0.00839	CbGpPWpGaD
Doxorubicin—NQO1—Oxidative Stress—FOS—migraine	0.000504	0.00824	CbGpPWpGaD
Doxorubicin—YWHAG—central nervous system—migraine	0.000502	0.00529	CbGeAlD
Doxorubicin—SLC22A16—Transmembrane transport of small molecules—HTR3A—migraine	0.000499	0.00816	CbGpPWpGaD
Doxorubicin—RALBP1—head—migraine	0.000497	0.00523	CbGeAlD
Doxorubicin—CBR1—NRF2 pathway—SLC6A4—migraine	0.000496	0.00811	CbGpPWpGaD
Doxorubicin—YWHAG—cerebellum—migraine	0.000491	0.00517	CbGeAlD
Doxorubicin—YWHAG—PDGFR-beta signaling pathway—LRP1—migraine	0.000489	0.008	CbGpPWpGaD
Doxorubicin—NOS3—head—migraine	0.000489	0.00515	CbGeAlD
Doxorubicin—RALBP1—nervous system—migraine	0.000471	0.00496	CbGeAlD
Doxorubicin—NOS1—brain—migraine	0.000466	0.00491	CbGeAlD
Doxorubicin—CBR1—head—migraine	0.000464	0.00488	CbGeAlD
Doxorubicin—NOS3—nervous system—migraine	0.000463	0.00488	CbGeAlD
Doxorubicin—NDUFS2—brain—migraine	0.000463	0.00488	CbGeAlD
Doxorubicin—NDUFS3—brain—migraine	0.000457	0.00482	CbGeAlD
Doxorubicin—RALBP1—central nervous system—migraine	0.000453	0.00478	CbGeAlD
Doxorubicin—XDH—Oxidative Stress—FOS—migraine	0.000452	0.00739	CbGpPWpGaD
Doxorubicin—NOS3—central nervous system—migraine	0.000446	0.0047	CbGeAlD
Doxorubicin—ABCC6—Transmembrane transport of small molecules—ATP1A2—migraine	0.000445	0.00728	CbGpPWpGaD
Doxorubicin—ABCC6—Transmembrane transport of small molecules—ATP1A3—migraine	0.000445	0.00728	CbGpPWpGaD
Doxorubicin—RALBP1—cerebellum—migraine	0.000443	0.00467	CbGeAlD
Doxorubicin—CBR1—nervous system—migraine	0.00044	0.00463	CbGeAlD
Doxorubicin—DHCR7—brain—migraine	0.000434	0.00458	CbGeAlD
Doxorubicin—NOS3—EGF/EGFR Signaling Pathway—MEF2D—migraine	0.000433	0.00708	CbGpPWpGaD
Doxorubicin—YWHAG—LKB1 signaling events—ESR1—migraine	0.00043	0.00704	CbGpPWpGaD
Doxorubicin—CBR1—central nervous system—migraine	0.000423	0.00446	CbGeAlD
Doxorubicin—CBR1—cerebellum—migraine	0.000414	0.00436	CbGeAlD
Doxorubicin—AKR1C3—cerebellum—migraine	0.000409	0.0043	CbGeAlD
Doxorubicin—YWHAG—brain—migraine	0.000399	0.0042	CbGeAlD
Doxorubicin—ABCG2—trigeminal ganglion—migraine	0.000397	0.00419	CbGeAlD
Doxorubicin—NQO1—Aryl Hydrocarbon Receptor—ESR1—migraine	0.000397	0.0065	CbGpPWpGaD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—ATP1A3—migraine	0.000389	0.00636	CbGpPWpGaD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—ATP1A2—migraine	0.000389	0.00636	CbGpPWpGaD
Doxorubicin—CYP1B1—cardiovascular system—migraine	0.000385	0.00406	CbGeAlD
Doxorubicin—ABCC6—Transmembrane transport of small molecules—HTR3A—migraine	0.000378	0.00619	CbGpPWpGaD
Doxorubicin—CBR1—NRF2 pathway—TGFBR2—migraine	0.000374	0.00612	CbGpPWpGaD
Doxorubicin—POR—cerebellum—migraine	0.000373	0.00393	CbGeAlD
Doxorubicin—NQO1—head—migraine	0.000372	0.00391	CbGeAlD
Doxorubicin—ABCC3—Fluoropyrimidine Activity—MTHFR—migraine	0.000369	0.00604	CbGpPWpGaD
Doxorubicin—RALBP1—brain—migraine	0.00036	0.00379	CbGeAlD
Doxorubicin—NOS1—Myometrial Relaxation and Contraction Pathways—CALCA—migraine	0.00036	0.00588	CbGpPWpGaD
Doxorubicin—NOS3—SHP2 signaling—BDNF—migraine	0.000359	0.00587	CbGpPWpGaD
Doxorubicin—NOS1—Monoamine Transport—TNF—migraine	0.000358	0.00586	CbGpPWpGaD
Doxorubicin—NOS3—Plasma membrane estrogen receptor signaling—ESR1—migraine	0.000355	0.00581	CbGpPWpGaD
Doxorubicin—NOS3—brain—migraine	0.000354	0.00373	CbGeAlD
Doxorubicin—NQO1—nervous system—migraine	0.000352	0.00371	CbGeAlD
Doxorubicin—NOS1—Spinal Cord Injury—BDNF—migraine	0.000347	0.00567	CbGpPWpGaD
Doxorubicin—NOS2—ATF-2 transcription factor network—ESR1—migraine	0.000342	0.00559	CbGpPWpGaD
Doxorubicin—NQO1—central nervous system—migraine	0.000339	0.00357	CbGeAlD
Doxorubicin—CBR1—brain—migraine	0.000336	0.00354	CbGeAlD
Doxorubicin—ABCC3—head—migraine	0.000334	0.00351	CbGeAlD
Doxorubicin—AKR1C3—brain—migraine	0.000332	0.0035	CbGeAlD
Doxorubicin—NQO1—cerebellum—migraine	0.000332	0.00349	CbGeAlD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—HTR3A—migraine	0.000331	0.00541	CbGpPWpGaD
Doxorubicin—ABCB1—blood vessel—migraine	0.000317	0.00334	CbGeAlD
Doxorubicin—ABCC3—nervous system—migraine	0.000316	0.00333	CbGeAlD
Doxorubicin—NOS1—Amyotrophic lateral sclerosis (ALS)—TNF—migraine	0.000312	0.0051	CbGpPWpGaD
Doxorubicin—NOS2—ATF-2 transcription factor network—FOS—migraine	0.000308	0.00504	CbGpPWpGaD
Doxorubicin—ABCC3—central nervous system—migraine	0.000304	0.00321	CbGeAlD
Doxorubicin—NOS2—IL12-mediated signaling events—FOS—migraine	0.000304	0.00497	CbGpPWpGaD
Doxorubicin—POR—brain—migraine	0.000303	0.00319	CbGeAlD
Doxorubicin—ABCC10—cerebellum—migraine	0.000296	0.00312	CbGeAlD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—HTR1A—migraine	0.000292	0.00477	CbGpPWpGaD
Doxorubicin—NQO1—NRF2 pathway—SLC6A4—migraine	0.000289	0.00474	CbGpPWpGaD
Doxorubicin—AURKA—Integrated Breast Cancer Pathway—TGFBR2—migraine	0.000288	0.00471	CbGpPWpGaD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—TAC1—migraine	0.000287	0.0047	CbGpPWpGaD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—SLC6A4—migraine	0.000282	0.00461	CbGpPWpGaD
Doxorubicin—NOS2—HIF-1-alpha transcription factor network—FOS—migraine	0.000281	0.0046	CbGpPWpGaD
Doxorubicin—NQO1—brain—migraine	0.000269	0.00284	CbGeAlD
Doxorubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—CALCA—migraine	0.000265	0.00434	CbGpPWpGaD
Doxorubicin—CYP2B6—cardiovascular system—migraine	0.000265	0.00279	CbGeAlD
Doxorubicin—NOS2—Spinal Cord Injury—BDNF—migraine	0.000262	0.00428	CbGpPWpGaD
Doxorubicin—CYP1B1—head—migraine	0.000261	0.00275	CbGeAlD
Doxorubicin—ABCG2—Fluoropyrimidine Activity—MTHFR—migraine	0.000255	0.00417	CbGpPWpGaD
Doxorubicin—CYP1B1—nervous system—migraine	0.000247	0.00261	CbGeAlD
Doxorubicin—ABCC3—brain—migraine	0.000242	0.00255	CbGeAlD
Doxorubicin—CYP2D6—brainstem—migraine	0.000241	0.00254	CbGeAlD
Doxorubicin—ABCC10—brain—migraine	0.000241	0.00253	CbGeAlD
Doxorubicin—NOS2—IL23-mediated signaling events—TNF—migraine	0.00024	0.00393	CbGpPWpGaD
Doxorubicin—NOS2—Circadian rythm related genes—NPS—migraine	0.00024	0.00393	CbGpPWpGaD
Doxorubicin—XDH—Selenium Micronutrient Network—MTHFR—migraine	0.000238	0.0039	CbGpPWpGaD
Doxorubicin—CYP1B1—central nervous system—migraine	0.000238	0.00251	CbGeAlD
Doxorubicin—NOS2—Circadian rythm related genes—SLC6A4—migraine	0.000235	0.00385	CbGpPWpGaD
Doxorubicin—NOS1—Spinal Cord Injury—FOS—migraine	0.000234	0.00384	CbGpPWpGaD
Doxorubicin—CYP1B1—cerebellum—migraine	0.000233	0.00245	CbGeAlD
Doxorubicin—RALBP1—EGF/EGFR Signaling Pathway—FOS—migraine	0.000228	0.00372	CbGpPWpGaD
Doxorubicin—NOS3—Leptin signaling pathway—ESR1—migraine	0.000219	0.00358	CbGpPWpGaD
Doxorubicin—NQO1—NRF2 pathway—TGFBR2—migraine	0.000218	0.00357	CbGpPWpGaD
Doxorubicin—NOS3—Myometrial Relaxation and Contraction Pathways—CALCA—migraine	0.000211	0.00345	CbGpPWpGaD
Doxorubicin—ABCC1—cerebellum—migraine	0.000209	0.00221	CbGeAlD
Doxorubicin—AURKA—Integrated Breast Cancer Pathway—ESR1—migraine	0.000208	0.0034	CbGpPWpGaD
Doxorubicin—NOS2—Circadian rythm related genes—HTR7—migraine	0.000206	0.00337	CbGpPWpGaD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—BDNF—migraine	0.000205	0.00335	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—TRPM8—migraine	0.000199	0.00325	CbGpPWpGaD
Doxorubicin—ABCB1—trigeminal ganglion—migraine	0.000196	0.00206	CbGeAlD
Doxorubicin—NQO1—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	0.000192	0.00315	CbGpPWpGaD
Doxorubicin—NQO1—Aryl Hydrocarbon Receptor—TNF—migraine	0.000192	0.00315	CbGpPWpGaD
Doxorubicin—CYP1B1—Aryl Hydrocarbon Receptor—ESR1—migraine	0.000191	0.00312	CbGpPWpGaD
Doxorubicin—YWHAG—ErbB1 downstream signaling—FOS—migraine	0.00019	0.0031	CbGpPWpGaD
Doxorubicin—CYP1B1—brain—migraine	0.000189	0.00199	CbGeAlD
Doxorubicin—NOS1—Myometrial Relaxation and Contraction Pathways—FOS—migraine	0.000188	0.00308	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—CACNA1A—migraine	0.000185	0.00302	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—CACNA1A—migraine	0.000185	0.00302	CbGpPWpGaD
Doxorubicin—ABCC3—NRF2 pathway—SLC6A4—migraine	0.000184	0.003	CbGpPWpGaD
Doxorubicin—CYP2B6—head—migraine	0.000179	0.00189	CbGeAlD
Doxorubicin—AURKA—EGF/EGFR Signaling Pathway—FOS—migraine	0.000177	0.0029	CbGpPWpGaD
Doxorubicin—NOS2—Spinal Cord Injury—FOS—migraine	0.000177	0.00289	CbGpPWpGaD
Doxorubicin—NOS1—Alzheimers Disease—TNF—migraine	0.000174	0.00284	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—CACNA1A—migraine	0.000174	0.00284	CbGpPWpGaD
Doxorubicin—ABCG2—cerebellum—migraine	0.000173	0.00183	CbGeAlD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—HTR2A—migraine	0.000173	0.00283	CbGpPWpGaD
Doxorubicin—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—migraine	0.000172	0.00281	CbGpPWpGaD
Doxorubicin—ABCC1—brain—migraine	0.00017	0.00179	CbGeAlD
Doxorubicin—CYP2B6—nervous system—migraine	0.00017	0.00179	CbGeAlD
Doxorubicin—NOS3—Corticotropin-releasing hormone—FOS—migraine	0.000168	0.00274	CbGpPWpGaD
Doxorubicin—YWHAG—PDGFR-beta signaling pathway—FOS—migraine	0.000165	0.0027	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—NPS—migraine	0.000164	0.00268	CbGpPWpGaD
Doxorubicin—CYP2B6—central nervous system—migraine	0.000164	0.00172	CbGeAlD
Doxorubicin—TOP2A—Circadian rythm related genes—SLC6A4—migraine	0.000161	0.00263	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—TRPM8—migraine	0.000157	0.00258	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—TRPM8—migraine	0.000156	0.00255	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—RAMP1—migraine	0.000154	0.00253	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CALCRL—migraine	0.000154	0.00253	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—ATP1A2—migraine	0.000151	0.00246	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—ATP1A3—migraine	0.000151	0.00246	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—CACNA1A—migraine	0.000148	0.00242	CbGpPWpGaD
Doxorubicin—NOS3—Angiopoietin receptor Tie2-mediated signaling—TNF—migraine	0.000147	0.0024	CbGpPWpGaD
Doxorubicin—ABCC2—NRF2 pathway—SLC6A4—migraine	0.000146	0.00238	CbGpPWpGaD
Doxorubicin—ABCB1—cardiovascular system—migraine	0.000142	0.00149	CbGeAlD
Doxorubicin—TOP2A—Circadian rythm related genes—HTR7—migraine	0.000141	0.00231	CbGpPWpGaD
Doxorubicin—ABCG2—brain—migraine	0.000141	0.00148	CbGeAlD
Doxorubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—FOS—migraine	0.000139	0.00227	CbGpPWpGaD
Doxorubicin—ABCC3—NRF2 pathway—TGFBR2—migraine	0.000138	0.00226	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—CACNA1A—migraine	0.000138	0.00225	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—TRPM8—migraine	0.000137	0.00224	CbGpPWpGaD
Doxorubicin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—migraine	0.000133	0.00218	CbGpPWpGaD
Doxorubicin—CYP2D6—head—migraine	0.000133	0.0014	CbGeAlD
Doxorubicin—CYP2B6—brain—migraine	0.00013	0.00137	CbGeAlD
Doxorubicin—CYP3A4—nervous system—migraine	0.000128	0.00135	CbGeAlD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—HTR3A—migraine	0.000128	0.00209	CbGpPWpGaD
Doxorubicin—CYP2D6—nervous system—migraine	0.000126	0.00133	CbGeAlD
Doxorubicin—NOS1—Spinal Cord Injury—TNF—migraine	0.000126	0.00206	CbGpPWpGaD
Doxorubicin—CYP3A4—central nervous system—migraine	0.000124	0.0013	CbGeAlD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BDNF—migraine	0.000122	0.00199	CbGpPWpGaD
Doxorubicin—CYP2D6—central nervous system—migraine	0.000122	0.00128	CbGeAlD
Doxorubicin—Asthenia—Verapamil—migraine	0.00012	0.000474	CcSEcCtD
Doxorubicin—Confusional state—Valproic Acid—migraine	0.000119	0.000472	CcSEcCtD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—ATP1A3—migraine	0.000119	0.00195	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—ATP1A2—migraine	0.000119	0.00195	CbGpPWpGaD
Doxorubicin—CYP2D6—cerebellum—migraine	0.000119	0.00125	CbGeAlD
Doxorubicin—Flatulence—Gabapentin—migraine	0.000119	0.000469	CcSEcCtD
Doxorubicin—Anaphylactic shock—Valproic Acid—migraine	0.000118	0.000469	CcSEcCtD
Doxorubicin—Oedema—Valproic Acid—migraine	0.000118	0.000469	CcSEcCtD
Doxorubicin—Bradycardia—Topiramate—migraine	0.000118	0.000468	CcSEcCtD
Doxorubicin—Pruritus—Verapamil—migraine	0.000118	0.000467	CcSEcCtD
Doxorubicin—Tension—Gabapentin—migraine	0.000118	0.000467	CcSEcCtD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—ATP1A3—migraine	0.000118	0.00193	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—ATP1A2—migraine	0.000118	0.00193	CbGpPWpGaD
Doxorubicin—Dysgeusia—Gabapentin—migraine	0.000118	0.000466	CcSEcCtD
Doxorubicin—Infection—Valproic Acid—migraine	0.000118	0.000465	CcSEcCtD
Doxorubicin—ABCG2—HIF-1-alpha transcription factor network—FOS—migraine	0.000117	0.00192	CbGpPWpGaD
Doxorubicin—Haemoglobin—Topiramate—migraine	0.000117	0.000462	CcSEcCtD
Doxorubicin—Nervousness—Gabapentin—migraine	0.000117	0.000462	CcSEcCtD
Doxorubicin—Rhinitis—Topiramate—migraine	0.000117	0.000461	CcSEcCtD
Doxorubicin—Back pain—Gabapentin—migraine	0.000116	0.00046	CcSEcCtD
Doxorubicin—Haemorrhage—Topiramate—migraine	0.000116	0.00046	CcSEcCtD
Doxorubicin—Hepatitis—Topiramate—migraine	0.000116	0.00046	CcSEcCtD
Doxorubicin—Nervous system disorder—Valproic Acid—migraine	0.000116	0.000459	CcSEcCtD
Doxorubicin—Vertigo—Timolol—migraine	0.000116	0.000459	CcSEcCtD
Doxorubicin—Thrombocytopenia—Valproic Acid—migraine	0.000116	0.000459	CcSEcCtD
Doxorubicin—Syncope—Timolol—migraine	0.000116	0.000458	CcSEcCtD
Doxorubicin—Hypoaesthesia—Topiramate—migraine	0.000116	0.000458	CcSEcCtD
Doxorubicin—Muscle spasms—Gabapentin—migraine	0.000116	0.000458	CcSEcCtD
Doxorubicin—Tachycardia—Valproic Acid—migraine	0.000116	0.000457	CcSEcCtD
Doxorubicin—Vomiting—Propranolol—migraine	0.000115	0.000457	CcSEcCtD
Doxorubicin—Pharyngitis—Topiramate—migraine	0.000115	0.000456	CcSEcCtD
Doxorubicin—Skin disorder—Valproic Acid—migraine	0.000115	0.000455	CcSEcCtD
Doxorubicin—Urinary tract disorder—Topiramate—migraine	0.000115	0.000454	CcSEcCtD
Doxorubicin—Oedema peripheral—Topiramate—migraine	0.000115	0.000453	CcSEcCtD
Doxorubicin—Hyperhidrosis—Valproic Acid—migraine	0.000114	0.000453	CcSEcCtD
Doxorubicin—Rash—Propranolol—migraine	0.000114	0.000453	CcSEcCtD
Doxorubicin—Dermatitis—Propranolol—migraine	0.000114	0.000452	CcSEcCtD
Doxorubicin—Diarrhoea—Verapamil—migraine	0.000114	0.000452	CcSEcCtD
Doxorubicin—Connective tissue disorder—Topiramate—migraine	0.000114	0.000452	CcSEcCtD
Doxorubicin—Palpitations—Timolol—migraine	0.000114	0.000452	CcSEcCtD
Doxorubicin—Urethral disorder—Topiramate—migraine	0.000114	0.000451	CcSEcCtD
Doxorubicin—Loss of consciousness—Timolol—migraine	0.000114	0.000449	CcSEcCtD
Doxorubicin—Vision blurred—Gabapentin—migraine	0.000113	0.000449	CcSEcCtD
Doxorubicin—Anorexia—Valproic Acid—migraine	0.000113	0.000447	CcSEcCtD
Doxorubicin—Cough—Timolol—migraine	0.000113	0.000446	CcSEcCtD
Doxorubicin—RALBP1—Signaling Pathways—HTR1D—migraine	0.000112	0.00184	CbGpPWpGaD
Doxorubicin—Visual impairment—Topiramate—migraine	0.000112	0.000443	CcSEcCtD
Doxorubicin—Ill-defined disorder—Gabapentin—migraine	0.000112	0.000442	CcSEcCtD
Doxorubicin—Hypertension—Timolol—migraine	0.000112	0.000441	CcSEcCtD
Doxorubicin—Anaemia—Gabapentin—migraine	0.000111	0.00044	CcSEcCtD
Doxorubicin—Hypotension—Valproic Acid—migraine	0.000111	0.000438	CcSEcCtD
Doxorubicin—Agitation—Gabapentin—migraine	0.000111	0.000437	CcSEcCtD
Doxorubicin—Dizziness—Verapamil—migraine	0.00011	0.000437	CcSEcCtD
Doxorubicin—NOS3—Myometrial Relaxation and Contraction Pathways—FOS—migraine	0.00011	0.00181	CbGpPWpGaD
Doxorubicin—Chest pain—Timolol—migraine	0.00011	0.000435	CcSEcCtD
Doxorubicin—Myalgia—Timolol—migraine	0.00011	0.000435	CcSEcCtD
Doxorubicin—Arthralgia—Timolol—migraine	0.00011	0.000435	CcSEcCtD
Doxorubicin—Erythema multiforme—Topiramate—migraine	0.00011	0.000435	CcSEcCtD
Doxorubicin—ABCC2—NRF2 pathway—TGFBR2—migraine	0.00011	0.0018	CbGpPWpGaD
Doxorubicin—Anxiety—Timolol—migraine	0.00011	0.000434	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000109	0.000432	CcSEcCtD
Doxorubicin—Discomfort—Timolol—migraine	0.000109	0.00043	CcSEcCtD
Doxorubicin—Eye disorder—Topiramate—migraine	0.000109	0.00043	CcSEcCtD
Doxorubicin—Malaise—Gabapentin—migraine	0.000108	0.000429	CcSEcCtD
Doxorubicin—Tinnitus—Topiramate—migraine	0.000108	0.000429	CcSEcCtD
Doxorubicin—Vertigo—Gabapentin—migraine	0.000108	0.000428	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Valproic Acid—migraine	0.000108	0.000427	CcSEcCtD
Doxorubicin—Flushing—Topiramate—migraine	0.000108	0.000427	CcSEcCtD
Doxorubicin—Cardiac disorder—Topiramate—migraine	0.000108	0.000427	CcSEcCtD
Doxorubicin—Syncope—Gabapentin—migraine	0.000108	0.000427	CcSEcCtD
Doxorubicin—Nausea—Propranolol—migraine	0.000108	0.000427	CcSEcCtD
Doxorubicin—Leukopenia—Gabapentin—migraine	0.000108	0.000426	CcSEcCtD
Doxorubicin—Dry mouth—Timolol—migraine	0.000108	0.000426	CcSEcCtD
Doxorubicin—Insomnia—Valproic Acid—migraine	0.000107	0.000424	CcSEcCtD
Doxorubicin—NOS3—EGF/EGFR Signaling Pathway—FOS—migraine	0.000107	0.00174	CbGpPWpGaD
Doxorubicin—Paraesthesia—Valproic Acid—migraine	0.000106	0.000421	CcSEcCtD
Doxorubicin—Palpitations—Gabapentin—migraine	0.000106	0.000421	CcSEcCtD
Doxorubicin—Confusional state—Timolol—migraine	0.000106	0.000421	CcSEcCtD
Doxorubicin—Vomiting—Verapamil—migraine	0.000106	0.00042	CcSEcCtD
Doxorubicin—Loss of consciousness—Gabapentin—migraine	0.000106	0.000418	CcSEcCtD
Doxorubicin—Dyspnoea—Valproic Acid—migraine	0.000106	0.000418	CcSEcCtD
Doxorubicin—Angiopathy—Topiramate—migraine	0.000105	0.000417	CcSEcCtD
Doxorubicin—Oedema—Timolol—migraine	0.000105	0.000417	CcSEcCtD
Doxorubicin—Anaphylactic shock—Timolol—migraine	0.000105	0.000417	CcSEcCtD
Doxorubicin—Rash—Verapamil—migraine	0.000105	0.000417	CcSEcCtD
Doxorubicin—Somnolence—Valproic Acid—migraine	0.000105	0.000417	CcSEcCtD
Doxorubicin—Dermatitis—Verapamil—migraine	0.000105	0.000416	CcSEcCtD
Doxorubicin—Immune system disorder—Topiramate—migraine	0.000105	0.000415	CcSEcCtD
Doxorubicin—Cough—Gabapentin—migraine	0.000105	0.000415	CcSEcCtD
Doxorubicin—NOS1—Disease—LRP1—migraine	0.000105	0.00172	CbGpPWpGaD
Doxorubicin—Mediastinal disorder—Topiramate—migraine	0.000105	0.000415	CcSEcCtD
Doxorubicin—Infection—Timolol—migraine	0.000105	0.000414	CcSEcCtD
Doxorubicin—Headache—Verapamil—migraine	0.000105	0.000414	CcSEcCtD
Doxorubicin—RALBP1—Signaling Pathways—HTR2B—migraine	0.000104	0.00171	CbGpPWpGaD
Doxorubicin—Chills—Topiramate—migraine	0.000104	0.000413	CcSEcCtD
Doxorubicin—Dyspepsia—Valproic Acid—migraine	0.000104	0.000412	CcSEcCtD
Doxorubicin—Convulsion—Gabapentin—migraine	0.000104	0.000412	CcSEcCtD
Doxorubicin—Hypertension—Gabapentin—migraine	0.000104	0.000411	CcSEcCtD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—ATP1A3—migraine	0.000104	0.0017	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—ATP1A2—migraine	0.000104	0.0017	CbGpPWpGaD
Doxorubicin—Shock—Timolol—migraine	0.000104	0.00041	CcSEcCtD
Doxorubicin—Nervous system disorder—Timolol—migraine	0.000103	0.000409	CcSEcCtD
Doxorubicin—Decreased appetite—Valproic Acid—migraine	0.000103	0.000407	CcSEcCtD
Doxorubicin—Alopecia—Topiramate—migraine	0.000103	0.000406	CcSEcCtD
Doxorubicin—XDH—Selenium Micronutrient Network—TNF—migraine	0.000103	0.00168	CbGpPWpGaD
Doxorubicin—Arthralgia—Gabapentin—migraine	0.000102	0.000405	CcSEcCtD
Doxorubicin—Chest pain—Gabapentin—migraine	0.000102	0.000405	CcSEcCtD
Doxorubicin—Myalgia—Gabapentin—migraine	0.000102	0.000405	CcSEcCtD
Doxorubicin—Skin disorder—Timolol—migraine	0.000102	0.000405	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Valproic Acid—migraine	0.000102	0.000404	CcSEcCtD
Doxorubicin—Fatigue—Valproic Acid—migraine	0.000102	0.000404	CcSEcCtD
Doxorubicin—Anxiety—Gabapentin—migraine	0.000102	0.000404	CcSEcCtD
Doxorubicin—Hyperhidrosis—Timolol—migraine	0.000102	0.000403	CcSEcCtD
Doxorubicin—Mental disorder—Topiramate—migraine	0.000102	0.000403	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000102	0.000402	CcSEcCtD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—HTR3A—migraine	0.000101	0.00166	CbGpPWpGaD
Doxorubicin—Pain—Valproic Acid—migraine	0.000101	0.000401	CcSEcCtD
Doxorubicin—Constipation—Valproic Acid—migraine	0.000101	0.000401	CcSEcCtD
Doxorubicin—Malnutrition—Topiramate—migraine	0.000101	0.0004	CcSEcCtD
Doxorubicin—Erythema—Topiramate—migraine	0.000101	0.0004	CcSEcCtD
Doxorubicin—Discomfort—Gabapentin—migraine	0.000101	0.0004	CcSEcCtD
Doxorubicin—Anorexia—Timolol—migraine	0.0001	0.000398	CcSEcCtD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—HTR3A—migraine	0.0001	0.00164	CbGpPWpGaD
Doxorubicin—Dry mouth—Gabapentin—migraine	0.0001	0.000396	CcSEcCtD
Doxorubicin—Flatulence—Topiramate—migraine	9.97e-05	0.000395	CcSEcCtD
Doxorubicin—Tension—Topiramate—migraine	9.93e-05	0.000393	CcSEcCtD
Doxorubicin—Nausea—Verapamil—migraine	9.92e-05	0.000392	CcSEcCtD
Doxorubicin—Dysgeusia—Topiramate—migraine	9.91e-05	0.000392	CcSEcCtD
Doxorubicin—Confusional state—Gabapentin—migraine	9.9e-05	0.000392	CcSEcCtD
Doxorubicin—Hypotension—Timolol—migraine	9.85e-05	0.00039	CcSEcCtD
Doxorubicin—Nervousness—Topiramate—migraine	9.83e-05	0.000389	CcSEcCtD
Doxorubicin—Oedema—Gabapentin—migraine	9.82e-05	0.000388	CcSEcCtD
Doxorubicin—Anaphylactic shock—Gabapentin—migraine	9.82e-05	0.000388	CcSEcCtD
Doxorubicin—Back pain—Topiramate—migraine	9.79e-05	0.000387	CcSEcCtD
Doxorubicin—Feeling abnormal—Valproic Acid—migraine	9.76e-05	0.000386	CcSEcCtD
Doxorubicin—Infection—Gabapentin—migraine	9.75e-05	0.000386	CcSEcCtD
Doxorubicin—Muscle spasms—Topiramate—migraine	9.73e-05	0.000385	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Valproic Acid—migraine	9.68e-05	0.000383	CcSEcCtD
Doxorubicin—Shock—Gabapentin—migraine	9.66e-05	0.000382	CcSEcCtD
Doxorubicin—CYP2D6—brain—migraine	9.65e-05	0.00102	CbGeAlD
Doxorubicin—Nervous system disorder—Gabapentin—migraine	9.63e-05	0.000381	CcSEcCtD
Doxorubicin—Thrombocytopenia—Gabapentin—migraine	9.61e-05	0.00038	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Timolol—migraine	9.61e-05	0.00038	CcSEcCtD
Doxorubicin—ABCB1—head—migraine	9.58e-05	0.00101	CbGeAlD
Doxorubicin—Tachycardia—Gabapentin—migraine	9.58e-05	0.000379	CcSEcCtD
Doxorubicin—Vision blurred—Topiramate—migraine	9.54e-05	0.000377	CcSEcCtD
Doxorubicin—Skin disorder—Gabapentin—migraine	9.54e-05	0.000377	CcSEcCtD
Doxorubicin—Insomnia—Timolol—migraine	9.54e-05	0.000377	CcSEcCtD
Doxorubicin—NOS2—Spinal Cord Injury—TNF—migraine	9.51e-05	0.00156	CbGpPWpGaD
Doxorubicin—Hyperhidrosis—Gabapentin—migraine	9.49e-05	0.000375	CcSEcCtD
Doxorubicin—Paraesthesia—Timolol—migraine	9.47e-05	0.000375	CcSEcCtD
Doxorubicin—Urticaria—Valproic Acid—migraine	9.41e-05	0.000372	CcSEcCtD
Doxorubicin—Dyspnoea—Timolol—migraine	9.4e-05	0.000372	CcSEcCtD
Doxorubicin—Ill-defined disorder—Topiramate—migraine	9.39e-05	0.000371	CcSEcCtD
Doxorubicin—Somnolence—Timolol—migraine	9.37e-05	0.000371	CcSEcCtD
Doxorubicin—Body temperature increased—Valproic Acid—migraine	9.36e-05	0.00037	CcSEcCtD
Doxorubicin—Abdominal pain—Valproic Acid—migraine	9.36e-05	0.00037	CcSEcCtD
Doxorubicin—Anorexia—Gabapentin—migraine	9.36e-05	0.00037	CcSEcCtD
Doxorubicin—Anaemia—Topiramate—migraine	9.35e-05	0.00037	CcSEcCtD
Doxorubicin—Agitation—Topiramate—migraine	9.3e-05	0.000368	CcSEcCtD
Doxorubicin—Dyspepsia—Timolol—migraine	9.28e-05	0.000367	CcSEcCtD
Doxorubicin—CYP1B1—Aryl Hydrocarbon Receptor—TNF—migraine	9.24e-05	0.00151	CbGpPWpGaD
Doxorubicin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	9.24e-05	0.00151	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—LRP1—migraine	9.19e-05	0.0015	CbGpPWpGaD
Doxorubicin—Hypotension—Gabapentin—migraine	9.17e-05	0.000363	CcSEcCtD
Doxorubicin—Decreased appetite—Timolol—migraine	9.16e-05	0.000363	CcSEcCtD
Doxorubicin—Malaise—Topiramate—migraine	9.13e-05	0.000361	CcSEcCtD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR1—migraine	9.12e-05	0.00149	CbGpPWpGaD
Doxorubicin—Gastrointestinal disorder—Timolol—migraine	9.1e-05	0.00036	CcSEcCtD
Doxorubicin—Vertigo—Topiramate—migraine	9.09e-05	0.00036	CcSEcCtD
Doxorubicin—Fatigue—Timolol—migraine	9.09e-05	0.00036	CcSEcCtD
Doxorubicin—ABCB1—nervous system—migraine	9.09e-05	0.000957	CbGeAlD
Doxorubicin—Syncope—Topiramate—migraine	9.08e-05	0.000359	CcSEcCtD
Doxorubicin—Leukopenia—Topiramate—migraine	9.06e-05	0.000358	CcSEcCtD
Doxorubicin—Pain—Timolol—migraine	9.02e-05	0.000357	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Gabapentin—migraine	8.94e-05	0.000354	CcSEcCtD
Doxorubicin—Palpitations—Topiramate—migraine	8.94e-05	0.000354	CcSEcCtD
Doxorubicin—Loss of consciousness—Topiramate—migraine	8.9e-05	0.000352	CcSEcCtD
Doxorubicin—Insomnia—Gabapentin—migraine	8.88e-05	0.000351	CcSEcCtD
Doxorubicin—Cough—Topiramate—migraine	8.83e-05	0.000349	CcSEcCtD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—HTR3A—migraine	8.83e-05	0.00144	CbGpPWpGaD
Doxorubicin—Paraesthesia—Gabapentin—migraine	8.82e-05	0.000349	CcSEcCtD
Doxorubicin—Convulsion—Topiramate—migraine	8.77e-05	0.000347	CcSEcCtD
Doxorubicin—Dyspnoea—Gabapentin—migraine	8.75e-05	0.000346	CcSEcCtD
Doxorubicin—ABCB1—central nervous system—migraine	8.75e-05	0.000921	CbGeAlD
Doxorubicin—Hypertension—Topiramate—migraine	8.74e-05	0.000346	CcSEcCtD
Doxorubicin—Somnolence—Gabapentin—migraine	8.73e-05	0.000345	CcSEcCtD
Doxorubicin—Hypersensitivity—Valproic Acid—migraine	8.73e-05	0.000345	CcSEcCtD
Doxorubicin—Feeling abnormal—Timolol—migraine	8.69e-05	0.000344	CcSEcCtD
Doxorubicin—Dyspepsia—Gabapentin—migraine	8.64e-05	0.000342	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Timolol—migraine	8.62e-05	0.000341	CcSEcCtD
Doxorubicin—Arthralgia—Topiramate—migraine	8.62e-05	0.000341	CcSEcCtD
Doxorubicin—Chest pain—Topiramate—migraine	8.62e-05	0.000341	CcSEcCtD
Doxorubicin—Myalgia—Topiramate—migraine	8.62e-05	0.000341	CcSEcCtD
Doxorubicin—Anxiety—Topiramate—migraine	8.59e-05	0.00034	CcSEcCtD
Doxorubicin—AKR1C3—Signaling Pathways—RAMP1—migraine	8.56e-05	0.0014	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CALCRL—migraine	8.56e-05	0.0014	CbGpPWpGaD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	8.56e-05	0.000339	CcSEcCtD
Doxorubicin—ABCB1—cerebellum—migraine	8.55e-05	0.0009	CbGeAlD
Doxorubicin—Decreased appetite—Gabapentin—migraine	8.53e-05	0.000338	CcSEcCtD
Doxorubicin—Discomfort—Topiramate—migraine	8.51e-05	0.000337	CcSEcCtD
Doxorubicin—Asthenia—Valproic Acid—migraine	8.5e-05	0.000336	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Gabapentin—migraine	8.48e-05	0.000335	CcSEcCtD
Doxorubicin—Fatigue—Gabapentin—migraine	8.46e-05	0.000335	CcSEcCtD
Doxorubicin—Dry mouth—Topiramate—migraine	8.43e-05	0.000333	CcSEcCtD
Doxorubicin—Constipation—Gabapentin—migraine	8.4e-05	0.000332	CcSEcCtD
Doxorubicin—Pain—Gabapentin—migraine	8.4e-05	0.000332	CcSEcCtD
Doxorubicin—Pruritus—Valproic Acid—migraine	8.38e-05	0.000331	CcSEcCtD
Doxorubicin—Urticaria—Timolol—migraine	8.38e-05	0.000331	CcSEcCtD
Doxorubicin—Body temperature increased—Timolol—migraine	8.33e-05	0.00033	CcSEcCtD
Doxorubicin—Abdominal pain—Timolol—migraine	8.33e-05	0.00033	CcSEcCtD
Doxorubicin—Confusional state—Topiramate—migraine	8.33e-05	0.000329	CcSEcCtD
Doxorubicin—Oedema—Topiramate—migraine	8.26e-05	0.000327	CcSEcCtD
Doxorubicin—Infection—Topiramate—migraine	8.21e-05	0.000325	CcSEcCtD
Doxorubicin—Shock—Topiramate—migraine	8.13e-05	0.000321	CcSEcCtD
Doxorubicin—Diarrhoea—Valproic Acid—migraine	8.1e-05	0.000321	CcSEcCtD
Doxorubicin—Nervous system disorder—Topiramate—migraine	8.1e-05	0.00032	CcSEcCtD
Doxorubicin—Feeling abnormal—Gabapentin—migraine	8.09e-05	0.00032	CcSEcCtD
Doxorubicin—Thrombocytopenia—Topiramate—migraine	8.09e-05	0.00032	CcSEcCtD
Doxorubicin—Tachycardia—Topiramate—migraine	8.06e-05	0.000319	CcSEcCtD
Doxorubicin—NQO1—Metabolism—CACNA1A—migraine	8.04e-05	0.00132	CbGpPWpGaD
Doxorubicin—Gastrointestinal pain—Gabapentin—migraine	8.03e-05	0.000318	CcSEcCtD
Doxorubicin—Skin disorder—Topiramate—migraine	8.02e-05	0.000317	CcSEcCtD
Doxorubicin—Hyperhidrosis—Topiramate—migraine	7.99e-05	0.000316	CcSEcCtD
Doxorubicin—NOS2—Disease—LRP1—migraine	7.91e-05	0.00129	CbGpPWpGaD
Doxorubicin—Anorexia—Topiramate—migraine	7.87e-05	0.000311	CcSEcCtD
Doxorubicin—Dizziness—Valproic Acid—migraine	7.83e-05	0.00031	CcSEcCtD
Doxorubicin—Urticaria—Gabapentin—migraine	7.8e-05	0.000309	CcSEcCtD
Doxorubicin—Hypersensitivity—Timolol—migraine	7.77e-05	0.000307	CcSEcCtD
Doxorubicin—Body temperature increased—Gabapentin—migraine	7.76e-05	0.000307	CcSEcCtD
Doxorubicin—Abdominal pain—Gabapentin—migraine	7.76e-05	0.000307	CcSEcCtD
Doxorubicin—AKR1C3—Metabolism—CACNA1A—migraine	7.76e-05	0.00127	CbGpPWpGaD
Doxorubicin—Hypotension—Topiramate—migraine	7.72e-05	0.000305	CcSEcCtD
Doxorubicin—Asthenia—Timolol—migraine	7.56e-05	0.000299	CcSEcCtD
Doxorubicin—Vomiting—Valproic Acid—migraine	7.53e-05	0.000298	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Topiramate—migraine	7.53e-05	0.000298	CcSEcCtD
Doxorubicin—Insomnia—Topiramate—migraine	7.47e-05	0.000296	CcSEcCtD
Doxorubicin—YWHAG—Apoptosis—TNF—migraine	7.47e-05	0.00122	CbGpPWpGaD
Doxorubicin—Rash—Valproic Acid—migraine	7.47e-05	0.000295	CcSEcCtD
Doxorubicin—Dermatitis—Valproic Acid—migraine	7.46e-05	0.000295	CcSEcCtD
Doxorubicin—Pruritus—Timolol—migraine	7.46e-05	0.000295	CcSEcCtD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—TNF—migraine	7.43e-05	0.00122	CbGpPWpGaD
Doxorubicin—Headache—Valproic Acid—migraine	7.42e-05	0.000294	CcSEcCtD
Doxorubicin—Paraesthesia—Topiramate—migraine	7.42e-05	0.000293	CcSEcCtD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—TRPM8—migraine	7.41e-05	0.00121	CbGpPWpGaD
Doxorubicin—Dyspnoea—Topiramate—migraine	7.36e-05	0.000291	CcSEcCtD
Doxorubicin—Somnolence—Topiramate—migraine	7.34e-05	0.00029	CcSEcCtD
Doxorubicin—Dyspepsia—Topiramate—migraine	7.27e-05	0.000288	CcSEcCtD
Doxorubicin—AKR1C3—Disease—LRP1—migraine	7.27e-05	0.00119	CbGpPWpGaD
Doxorubicin—Hypersensitivity—Gabapentin—migraine	7.23e-05	0.000286	CcSEcCtD
Doxorubicin—NOS3—Signaling Pathways—RAMP1—migraine	7.23e-05	0.00118	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CALCRL—migraine	7.23e-05	0.00118	CbGpPWpGaD
Doxorubicin—Diarrhoea—Timolol—migraine	7.21e-05	0.000285	CcSEcCtD
Doxorubicin—XDH—Metabolism—CACNA1A—migraine	7.21e-05	0.00118	CbGpPWpGaD
Doxorubicin—Decreased appetite—Topiramate—migraine	7.18e-05	0.000284	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Topiramate—migraine	7.13e-05	0.000282	CcSEcCtD
Doxorubicin—Fatigue—Topiramate—migraine	7.12e-05	0.000282	CcSEcCtD
Doxorubicin—Pain—Topiramate—migraine	7.06e-05	0.000279	CcSEcCtD
Doxorubicin—Constipation—Topiramate—migraine	7.06e-05	0.000279	CcSEcCtD
Doxorubicin—RALBP1—Signaling Pathways—NOTCH4—migraine	7.05e-05	0.00115	CbGpPWpGaD
Doxorubicin—Asthenia—Gabapentin—migraine	7.04e-05	0.000279	CcSEcCtD
Doxorubicin—Nausea—Valproic Acid—migraine	7.03e-05	0.000278	CcSEcCtD
Doxorubicin—Dizziness—Timolol—migraine	6.97e-05	0.000276	CcSEcCtD
Doxorubicin—Pruritus—Gabapentin—migraine	6.95e-05	0.000275	CcSEcCtD
Doxorubicin—ABCB1—brain—migraine	6.94e-05	0.000731	CbGeAlD
Doxorubicin—Feeling abnormal—Topiramate—migraine	6.81e-05	0.000269	CcSEcCtD
Doxorubicin—RALBP1—Signaling Pathways—HTR1B—migraine	6.8e-05	0.00111	CbGpPWpGaD
Doxorubicin—NOS1—Disease—CALCA—migraine	6.76e-05	0.00111	CbGpPWpGaD
Doxorubicin—Gastrointestinal pain—Topiramate—migraine	6.75e-05	0.000267	CcSEcCtD
Doxorubicin—Diarrhoea—Gabapentin—migraine	6.72e-05	0.000266	CcSEcCtD
Doxorubicin—Vomiting—Timolol—migraine	6.7e-05	0.000265	CcSEcCtD
Doxorubicin—Rash—Timolol—migraine	6.65e-05	0.000263	CcSEcCtD
Doxorubicin—Dermatitis—Timolol—migraine	6.64e-05	0.000263	CcSEcCtD
Doxorubicin—Headache—Timolol—migraine	6.6e-05	0.000261	CcSEcCtD
Doxorubicin—Urticaria—Topiramate—migraine	6.56e-05	0.00026	CcSEcCtD
Doxorubicin—NOS3—Metabolism—CACNA1A—migraine	6.56e-05	0.00107	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—HTR1A—migraine	6.55e-05	0.00107	CbGpPWpGaD
Doxorubicin—Abdominal pain—Topiramate—migraine	6.53e-05	0.000258	CcSEcCtD
Doxorubicin—Body temperature increased—Topiramate—migraine	6.53e-05	0.000258	CcSEcCtD
Doxorubicin—Dizziness—Gabapentin—migraine	6.49e-05	0.000257	CcSEcCtD
Doxorubicin—RALBP1—Signaling Pathways—PGR—migraine	6.45e-05	0.00105	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—NPS—migraine	6.45e-05	0.00105	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TAC1—migraine	6.45e-05	0.00105	CbGpPWpGaD
Doxorubicin—ABCB1—HIF-1-alpha transcription factor network—FOS—migraine	6.34e-05	0.00104	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—HTR2C—migraine	6.32e-05	0.00103	CbGpPWpGaD
Doxorubicin—Nausea—Timolol—migraine	6.26e-05	0.000248	CcSEcCtD
Doxorubicin—Vomiting—Gabapentin—migraine	6.24e-05	0.000247	CcSEcCtD
Doxorubicin—AKR1C3—Signaling Pathways—HTR1D—migraine	6.22e-05	0.00102	CbGpPWpGaD
Doxorubicin—Rash—Gabapentin—migraine	6.19e-05	0.000245	CcSEcCtD
Doxorubicin—Dermatitis—Gabapentin—migraine	6.18e-05	0.000245	CcSEcCtD
Doxorubicin—Headache—Gabapentin—migraine	6.15e-05	0.000243	CcSEcCtD
Doxorubicin—RALBP1—Signaling Pathways—EDNRA—migraine	6.15e-05	0.00101	CbGpPWpGaD
Doxorubicin—NOS3—Disease—LRP1—migraine	6.14e-05	0.001	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—MTHFR—migraine	6.11e-05	0.001	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—MTHFR—migraine	6.11e-05	0.001	CbGpPWpGaD
Doxorubicin—Hypersensitivity—Topiramate—migraine	6.09e-05	0.000241	CcSEcCtD
Doxorubicin—RALBP1—Signaling Pathways—NOTCH3—migraine	5.99e-05	0.00098	CbGpPWpGaD
Doxorubicin—Asthenia—Topiramate—migraine	5.93e-05	0.000234	CcSEcCtD
Doxorubicin—RALBP1—Signaling Pathways—CALCA—migraine	5.92e-05	0.000968	CbGpPWpGaD
Doxorubicin—Pruritus—Topiramate—migraine	5.84e-05	0.000231	CcSEcCtD
Doxorubicin—Nausea—Gabapentin—migraine	5.83e-05	0.000231	CcSEcCtD
Doxorubicin—AKR1C3—Signaling Pathways—HTR2B—migraine	5.78e-05	0.000946	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—MTHFR—migraine	5.75e-05	0.00094	CbGpPWpGaD
Doxorubicin—Diarrhoea—Topiramate—migraine	5.65e-05	0.000224	CcSEcCtD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—ATP1A3—migraine	5.61e-05	0.000918	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—ATP1A2—migraine	5.61e-05	0.000918	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—HTR7—migraine	5.54e-05	0.000906	CbGpPWpGaD
Doxorubicin—Dizziness—Topiramate—migraine	5.46e-05	0.000216	CcSEcCtD
Doxorubicin—NOS1—Disease—TGFBR2—migraine	5.44e-05	0.000891	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—CACNA1A—migraine	5.32e-05	0.00087	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HTR1D—migraine	5.26e-05	0.00086	CbGpPWpGaD
Doxorubicin—Vomiting—Topiramate—migraine	5.25e-05	0.000208	CcSEcCtD
Doxorubicin—Rash—Topiramate—migraine	5.21e-05	0.000206	CcSEcCtD
Doxorubicin—Dermatitis—Topiramate—migraine	5.2e-05	0.000206	CcSEcCtD
Doxorubicin—Headache—Topiramate—migraine	5.17e-05	0.000205	CcSEcCtD
Doxorubicin—ABCC3—Metabolism—CACNA1A—migraine	5.1e-05	0.000834	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CALCA—migraine	5.1e-05	0.000834	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—LRP1—migraine	5.09e-05	0.000833	CbGpPWpGaD
Doxorubicin—Nausea—Topiramate—migraine	4.91e-05	0.000194	CcSEcCtD
Doxorubicin—DHCR7—Metabolism—MTHFR—migraine	4.89e-05	0.000799	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HTR2B—migraine	4.89e-05	0.000799	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—HTR3A—migraine	4.77e-05	0.000781	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TGFBR2—migraine	4.77e-05	0.00078	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CALCA—migraine	4.68e-05	0.000766	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—MTHFR—migraine	4.56e-05	0.000745	CbGpPWpGaD
Doxorubicin—NOS1—Disease—MTHFR—migraine	4.42e-05	0.000723	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—migraine	4.42e-05	0.000723	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—LRP1—migraine	4.3e-05	0.000704	CbGpPWpGaD
Doxorubicin—NOS2—Disease—TGFBR2—migraine	4.11e-05	0.000672	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	4.01e-05	0.000655	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CACNA1A—migraine	3.99e-05	0.000653	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CALCA—migraine	3.96e-05	0.000647	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NOTCH4—migraine	3.91e-05	0.000639	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—HTR2A—migraine	3.88e-05	0.000634	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CACNA1A—migraine	3.86e-05	0.000632	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—TGFBR2—migraine	3.77e-05	0.000617	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—HTR1B—migraine	3.77e-05	0.000616	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—LRP1—migraine	3.74e-05	0.000612	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—HTR1A—migraine	3.63e-05	0.000593	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PGR—migraine	3.57e-05	0.000584	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TAC1—migraine	3.57e-05	0.000584	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NPS—migraine	3.57e-05	0.000584	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CACNA1A—migraine	3.51e-05	0.000575	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—HTR2C—migraine	3.5e-05	0.000573	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—ESR1—migraine	3.44e-05	0.000563	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—EDNRA—migraine	3.41e-05	0.000557	CbGpPWpGaD
Doxorubicin—NOS2—Disease—MTHFR—migraine	3.33e-05	0.000546	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NOTCH3—migraine	3.32e-05	0.000543	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—NOTCH4—migraine	3.3e-05	0.00054	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CALCA—migraine	3.28e-05	0.000537	CbGpPWpGaD
Doxorubicin—NOS3—Disease—TGFBR2—migraine	3.19e-05	0.000522	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HTR1B—migraine	3.18e-05	0.000521	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—HTR7—migraine	3.07e-05	0.000502	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HTR1A—migraine	3.06e-05	0.000501	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—MTHFR—migraine	3.06e-05	0.000501	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—NPS—migraine	3.02e-05	0.000494	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PGR—migraine	3.02e-05	0.000494	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TAC1—migraine	3.02e-05	0.000494	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	3e-05	0.000491	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HTR2C—migraine	2.96e-05	0.000484	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—TNF—migraine	2.95e-05	0.000483	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—EDNRA—migraine	2.88e-05	0.000471	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—NOTCH3—migraine	2.81e-05	0.000459	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CALCA—migraine	2.77e-05	0.000453	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—MTHFR—migraine	2.66e-05	0.000435	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TGFBR2—migraine	2.64e-05	0.000432	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HTR7—migraine	2.59e-05	0.000424	CbGpPWpGaD
Doxorubicin—NOS3—Disease—MTHFR—migraine	2.59e-05	0.000424	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CACNA1A—migraine	2.58e-05	0.000421	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—MTHFR—migraine	2.57e-05	0.00042	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CALCA—migraine	2.41e-05	0.000395	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—MTHFR—migraine	2.39e-05	0.00039	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TGFBR2—migraine	2.23e-05	0.000365	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—MTHFR—migraine	2.17e-05	0.000355	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—HTR2A—migraine	2.15e-05	0.000352	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—TGFBR2—migraine	1.94e-05	0.000318	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—ESR1—migraine	1.91e-05	0.000312	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CACNA1A—migraine	1.9e-05	0.000311	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HTR2A—migraine	1.82e-05	0.000297	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CACNA1A—migraine	1.79e-05	0.000293	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—MTHFR—migraine	1.76e-05	0.000288	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—MTHFR—migraine	1.69e-05	0.000276	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—ESR1—migraine	1.61e-05	0.000264	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MTHFR—migraine	1.58e-05	0.000258	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—migraine	1.46e-05	0.000238	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—MTHFR—migraine	1.32e-05	0.000216	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—MTHFR—migraine	1.28e-05	0.000209	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CACNA1A—migraine	1.17e-05	0.000192	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—MTHFR—migraine	1.16e-05	0.00019	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—MTHFR—migraine	8.52e-06	0.000139	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—MTHFR—migraine	6.29e-06	0.000103	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—MTHFR—migraine	5.92e-06	9.69e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—MTHFR—migraine	3.87e-06	6.34e-05	CbGpPWpGaD
